DRHP vs Prospectus: What SEBI Really Requires Before an Indian Company Can List

When an Indian company decides to go public, it enters a process that is far more structured and regulated than most founders and senior management teams anticipate. The documentation alone can consume months of preparation, legal review, and coordination across departments. Among the most consequential documents in this process are the Draft Red Herring Prospectus and the final Prospectus — two instruments that are often confused with each other but serve distinctly different purposes at different stages of the IPO timeline.

This confusion is not trivial. Misunderstanding the role of each document, or the regulatory expectations attached to them, can delay a listing, invite regulatory scrutiny, or create material disclosure gaps that affect investor confidence. For CFOs, company secretaries, investment bankers, and legal teams managing a public offering, clarity on what each document contains, when it is filed, and what SEBI expects from each stage is foundational to a smooth listing process.

What the DRHP Actually Is and Why SEBI Scrutinises It So Closely

The Draft Red Herring Prospectus is a pre-filing disclosure document submitted to the Securities and Exchange Board of India before a company can publicly announce its intention to list. Understanding what drhp sebi requirements encompass helps clarify why this document carries such regulatory weight — it is not merely a draft in the informal sense, but a structured legal and financial disclosure that must meet specific content standards before SEBI will even begin its review process. You can find a detailed breakdown of the obligations and preparation considerations through this overview of drhp sebi preparation services, which outlines the scope of compliance work involved.

SEBI treats the DRHP as its primary window into the company’s financial health, governance structure, risk profile, and the terms of the proposed offering. The document is made available to the public on SEBI’s website during the review period, which allows institutional investors and analysts to begin forming views on the company well before a final offer price is set.

Why the DRHP Cannot Be Treated as a Preliminary Draft

Many management teams enter the DRHP preparation process with the assumption that this is a first draft — something that will be substantially revised before it matters. That assumption creates real operational risk. SEBI’s review process is triggered by this document, and any material omission, inconsistency, or factual inaccuracy can result in observation letters that pause the listing timeline, sometimes for months.

The DRHP must include audited financial statements, a detailed description of the business, information about promoters and their background, risk factors that are specific and material rather than generic, and a complete description of how the proceeds from the offering will be used. These are not placeholder sections. They must be substantiated, consistent across sections, and aligned with regulatory schedules prescribed under SEBI’s Issue of Capital and Disclosure Requirements Regulations.

The Role of the Merchant Banker in DRHP Preparation

The Book Running Lead Manager, commonly referred to as the BRLM, carries the primary responsibility for the accuracy and completeness of the DRHP. This is not merely a coordination role. The BRLM conducts due diligence, works with legal counsel to identify disclosure obligations, and certifies the document before submission. If SEBI identifies gaps, the BRLM is accountable alongside the issuer.

This shared accountability structure means that companies seeking to list must engage their investment bankers early and give them substantive access to internal operations, contracts, litigation history, and financial records. Delays in internal access almost always translate to delays in regulatory submission.

How the Final Prospectus Differs from the DRHP

Once SEBI issues its observations — a document that is sometimes called the SEBI observation letter — the company and its advisors can proceed to incorporate those observations into the final Prospectus. The Prospectus differs from the DRHP in one critical way: it contains the final offer price or price band, the exact number of shares being offered, and confirmed allotment details. The DRHP is intentionally silent on pricing because that determination happens through the book-building process, which occurs after SEBI completes its review.

The Prospectus is the document that is actually filed with the Registrar of Companies and forms the legal basis on which investors subscribe to shares. Any misrepresentation in the Prospectus carries direct legal liability for the issuer, directors, and the BRLM under Indian securities law.

Sections That Must Be Updated Between DRHP and Prospectus

The transition from DRHP to Prospectus is not simply a matter of inserting a price and printing. Several sections require substantive updating based on the time elapsed between initial filing and the final offer. Financial statements must reflect the most recent audited or reviewed period allowed under SEBI regulations. Material developments in litigation, regulatory actions, or business operations that occurred after the DRHP was filed must be disclosed.

Risk factors may also require revision if the business environment, competitive position, or regulatory framework has changed. This is a compliance obligation, not a discretionary editorial decision. Failing to update the Prospectus to reflect material post-DRHP developments is a disclosure violation that can lead to post-listing legal exposure, including investor claims and regulatory action.

The Price Band Disclosure and Its Implications

The inclusion of the price band in the Red Herring Prospectus — which is the version distributed to investors during the book-building period — marks the transition from internal regulatory review to active public offering. At this stage, the document becomes the basis on which retail and institutional investors make financial decisions. The accuracy of every statement in this document carries direct consequence.

SEBI requires that the price band be justified through a basis of issue price section, which must explain how the company arrived at its valuation. This section is reviewed carefully by analysts and institutional investors and must be internally consistent with the financial data and peer comparison disclosed elsewhere in the document.

See also: The Future of Smart Technology in Education

Common Points Where the DRHP Filing Process Breaks Down

In practice, DRHP preparation failures tend to cluster around a few recurring areas. Related party transaction disclosures are frequently incomplete because companies have not maintained the documentation discipline required to reconstruct years of inter-entity dealings. Litigation disclosures are another chronic problem area, particularly for companies with long operating histories where older disputes were not tracked systematically.

Promoter background disclosures also generate regulatory queries, especially in cases where promoters have been involved in other businesses that faced regulatory or legal scrutiny. SEBI’s position is that these disclosures should give investors a complete picture, not a curated one. The standard for materiality, under SEBI’s framework, errs on the side of inclusion rather than exclusion.

The Risk Factor Section as a Substantive Obligation

Risk factors in the DRHP are sometimes drafted as generic disclaimers borrowed from comparable filings. SEBI has been increasingly direct in its observation letters that risk factors must be specific to the issuer’s actual business, not boilerplate language that applies equally to any company in the sector.

A company that operates in a single geography, depends on a limited number of customers for a majority of its revenue, or holds licenses that are subject to periodic renewal must disclose these specifics clearly. Generic language about industry competition or regulatory uncertainty does not satisfy the disclosure standard when the company faces identifiable and specific risks that investors would consider material to their decision.

Financial Restatements and Their Impact on the Filing Timeline

If the auditors, BRLM, or legal counsel identify the need for financial restatements during the due diligence process, the DRHP cannot be filed until those restatements are completed and re-audited. This is one of the most significant timeline risks in any IPO process. Companies that have undergone complex restructuring, changed accounting policies, or have subsidiaries with inadequate financial records are particularly vulnerable to this delay.

Early identification of potential restatement triggers — ideally eighteen to twenty-four months before the intended listing — gives companies the time to address these issues without compressing the regulatory timeline.

What SEBI’s Observation Letter Means in Practice

SEBI’s observation letter is not an approval of the offering. This distinction matters more than it is often given credit for. The letter indicates that SEBI has no further comments on the disclosures as presented — it does not validate the business, endorse the price, or certify the accuracy of the information. Issuers and their advisors are required to include a disclaimer to this effect in the final Prospectus, as outlined in SEBI’s regulatory framework.

The observation letter is valid for a defined period, during which the company must complete the book-building process and file the final Prospectus. If that window lapses — due to market conditions, internal decisions, or regulatory complications — the company may need to refile the DRHP with updated financials, effectively restarting portions of the process.

Closing Considerations for Companies Preparing to List

The distinction between the DRHP and the final Prospectus is more than a procedural technicality. It reflects the structure of a disclosure-based regulatory system in which investors are expected to make informed decisions based on complete information provided at the right stage of the process. Companies that treat the DRHP as a compliance formality rather than a substantive obligation tend to encounter the most friction during SEBI’s review.

The practical implication for companies approaching a public offering is straightforward: preparation for the DRHP should begin well before the filing target date, internal record-keeping and disclosure tracking must be brought to a standard that can withstand regulatory scrutiny, and the team responsible for the document — legal, financial, and banking advisors — must have genuine access and sufficient time to do the work properly.

A delayed or incomplete DRHP does not simply slow down a listing. It can affect the market window the company was targeting, shift investor sentiment, and in some cases require disclosure of developments that would not have been relevant had the process moved on schedule. Managing the DRHP process with the same discipline applied to the underlying business decision to list is not overcaution — it is the baseline requirement for a credible public offering in India.